| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 9e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |